Il-6, Il-1β and cytokine-targeted therapy for COVID -19 patients: two more reasons to take into account statins?
作者信息
Mormile Raffaella
机构信息
Division of Pediatrics and Neonatology, Moscati Hospital, Aversa, Italy.
出版信息
Expert Rev Cardiovasc Ther. 2022 Mar;20(3):161-163. doi: 10.1080/14779072.2022.2058490. Epub 2022 Mar 28.
Abstract
摘要
相似文献
1
Il-6, Il-1β and cytokine-targeted therapy for COVID -19 patients: two more reasons to take into account statins?白细胞介素-6、白细胞介素-1β与针对新冠肺炎患者的细胞因子靶向治疗：他汀类药物还有两个值得考虑的理由？
Expert Rev Cardiovasc Ther. 2022 Mar;20(3):161-163. doi: 10.1080/14779072.2022.2058490. Epub 2022 Mar 28.
2
Multiplex Testing of the Effect of Statins on Disease Severity Risk in COVID-19 Cases.他汀类药物对 COVID-19 病例疾病严重程度风险的多重检测。
Methods Mol Biol. 2022;2511:273-284. doi: 10.1007/978-1-0716-2395-4_20.
3
COVID-19: Direct and Indirect Mechanisms of Statins.COVID-19：他汀类药物的直接和间接作用机制。
Int J Mol Sci. 2021 Apr 17;22(8):4177. doi: 10.3390/ijms22084177.
4
Increased expression of interleukin-1 in coronary artery disease with downregulatory effects of HMG-CoA reductase inhibitors.白细胞介素-1在冠状动脉疾病中的表达增加及HMG-CoA还原酶抑制剂的下调作用
Circulation. 2004 Apr 27;109(16):1966-72. doi: 10.1161/01.CIR.0000125700.33637.B1. Epub 2004 Mar 29.
5
Statins in COVID-19 infection: A rehash of old themes or truly a new hope?他汀类药物在新冠病毒感染中的应用：旧有观点的重复还是真正的新希望？
J Clin Lipidol. 2021 May-Jun;15(3):399-401. doi: 10.1016/j.jacl.2021.04.002. Epub 2021 Apr 21.
6
Could Statins Do More Than Lower Cholesterol in Patients With COVID-19?他汀类药物对新冠患者的作用会否不止于降低胆固醇？
JAMA. 2021 Jun 22;325(24):2424-2425. doi: 10.1001/jama.2021.8201.
7
Association of statins with inflammatory cytokines: a population-based Colaus study.他汀类药物与炎症细胞因子的相关性：基于人群的 Colaus 研究。
Atherosclerosis. 2011 Nov;219(1):253-8. doi: 10.1016/j.atherosclerosis.2011.07.117. Epub 2011 Aug 4.
8
Statins as candidate therapeutic agents for coronavirus disease 2019 (COVID-19).他汀类药物作为2019冠状病毒病（COVID-19）的候选治疗药物。
Chin Med J (Engl). 2020 Nov 2;134(4):407-409. doi: 10.1097/CM9.0000000000001205.
9
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility.他汀类药物作为COVID-19的辅助治疗：生物学和临床合理性。
Immunopharmacol Immunotoxicol. 2021 Feb;43(1):37-50. doi: 10.1080/08923973.2020.1863984. Epub 2021 Jan 6.
10
The role of statin therapy in COVID-19.他汀类药物治疗在新型冠状病毒肺炎中的作用。
Expert Rev Cardiovasc Ther. 2022 Jun;20(6):415-417. doi: 10.1080/14779072.2022.2081548. Epub 2022 May 30.
引用本文的文献
1
Familial Hypercholesterolemia Patients with COVID-19-Effective Cholesterol-Lowering Therapy is Urgent both during and after Infection.家族性高胆固醇血症合并新型冠状病毒肺炎患者——感染期间及感染后均急需有效的降胆固醇治疗
Rev Cardiovasc Med. 2022 Dec 19;23(12):410. doi: 10.31083/j.rcm2312410. eCollection 2022 Dec.
2
SARS-CoV-2 reinfection: Adding insult to dysfunctional endothelium in patients with atherosclerotic cardiovascular disease.严重急性呼吸综合征冠状病毒2型再感染：给动脉粥样硬化性心血管疾病患者本就功能失调的内皮增加损伤。
Atheroscler Plus. 2023 Sep;53:1-5. doi: 10.1016/j.athplu.2023.06.002. Epub 2023 Jun 2.
3
Statin Therapy to Improve Outcome of COVID-19 Patients: Useful or Not Useful?他汀类药物治疗改善COVID-19患者的预后：有用还是无用？
J Pers Med. 2022 Oct 1;12(10):1627. doi: 10.3390/jpm12101627.
本文引用的文献
1
Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association's COVID-19 Cardiovascular Disease Registry.新冠肺炎住院患者中他汀类药物和抗高血压药物使用与疾病严重程度的关系：美国心脏协会新冠肺炎心血管疾病注册研究的结果。
PLoS One. 2021 Jul 15;16(7):e0254635. doi: 10.1371/journal.pone.0254635. eCollection 2021.
2
Interleukin-1 and interleukin-6 inhibition compared with standard management in patients with COVID-19 and hyperinflammation: a cohort study.白细胞介素-1和白细胞介素-6抑制与COVID-19合并高炎症患者标准治疗的比较：一项队列研究
Lancet Rheumatol. 2021 Apr;3(4):e253-e261. doi: 10.1016/S2665-9913(21)00012-6. Epub 2021 Feb 3.
3
Association between antecedent statin use and decreased mortality in hospitalized patients with COVID-19.COVID-19 住院患者中使用他汀类药物前史与死亡率降低的关联。
Nat Commun. 2021 Feb 26;12(1):1325. doi: 10.1038/s41467-021-21553-1.
4
Statins as an adjunctive therapy for COVID-19: the biological and clinical plausibility.他汀类药物作为COVID-19的辅助治疗：生物学和临床合理性。
Immunopharmacol Immunotoxicol. 2021 Feb;43(1):37-50. doi: 10.1080/08923973.2020.1863984. Epub 2021 Jan 6.
5
Association between statin use and outcomes in patients with coronavirus disease 2019 (COVID-19): a nationwide cohort study.他汀类药物使用与 2019 冠状病毒病（COVID-19）患者结局的关系：一项全国性队列研究。
BMJ Open. 2020 Dec 4;10(12):e044421. doi: 10.1136/bmjopen-2020-044421.
6
Challenges for Drug Repurposing in the COVID-19 Pandemic Era.新冠疫情时代药物重新利用面临的挑战
Front Pharmacol. 2020 Nov 6;11:588654. doi: 10.3389/fphar.2020.588654. eCollection 2020.
7
More Good News on Statins and COVID-19.关于他汀类药物与新冠病毒的更多好消息。
Am J Cardiol. 2021 Jan 1;138:127-128. doi: 10.1016/j.amjcard.2020.10.026. Epub 2020 Oct 23.
8
Effect of statin therapy on SARS-CoV-2 infection-related mortality in hospitalized patients.他汀类药物治疗对住院患者 COVID-19 感染相关死亡率的影响。
Eur Heart J Cardiovasc Pharmacother. 2022 Feb 16;8(2):157-164. doi: 10.1093/ehjcvp/pvaa128.
9
Relation of Statin Use Prior to Admission to Severity and Recovery Among COVID-19 Inpatients.住院前使用他汀类药物与 COVID-19 住院患者严重程度和恢复的关系。
Am J Cardiol. 2020 Dec 1;136:149-155. doi: 10.1016/j.amjcard.2020.09.012. Epub 2020 Sep 16.
10
Clinical Management of Adult Coronavirus Infection Disease 2019 (COVID-19) Positive in the Setting of Low and Medium Intensity of Care: a Short Practical Review.成人新型冠状病毒感染疾病2019（COVID-19）在低强度和中等强度护理环境下呈阳性的临床管理：简短实用综述
SN Compr Clin Med. 2020;2(6):694-699. doi: 10.1007/s42399-020-00333-w. Epub 2020 May 29.
Zotero 插件